Piers Morgan, Uncensored. “A VERY Valuable Asset” Epteins Links to Mossad

Posted in Uncategorized | Leave a comment

GZERO: How the US went from global cop to King of the Jungle. Ian Bremmer

Posted in Uncategorized | Leave a comment

SCIAM: Why did Jeffrey Epstein cultivate famous scientists?

Why did Jeffrey Epstein cultivate famous scientists?

The Epstein files revive questions of whether the disgraced financier sought to merely cultivate famous scientists, or to shape science itself

By Dan Vergano edited by Clara Moskowitz

A group of men and women seated and standing for a group photograph in front of a round pink table.
Jeffrey Epstein with professors at a dinner he hosted at Harvard University in September 2004. Rick Friedman/Alamy

Ethics

Last December, the U.S. Department of Justice released its first batch of files on disgraced financier and convicted sex offender Jeffrey Epstein. Among the thousands of images was one video clip, the only one in the lot. It showed four seconds of the noted psychologist and writer Steven Pinker of Harvard University riding with Epstein on his now infamous private plane.

It wasn’t a great flight even in 2002, years before Epstein’s first criminal conviction, Pinker says of the trip, which was heading to a TED Talk. “I immediately disliked Epstein and thought he was a dilettante and a smartass,” he says. Pinker has not been accused of wrongdoing in connection with Epstein.

Epstein, who died in federal prison in 2019 while awaiting trial on sex trafficking charges, spent a lot of time talking to scientists. When more records are released from a reported stash of 5.2 million, now a month overdue, questions about what the “Epstein files” say about science and scientists are sure to arise. Already, e-mails dropped by a congressional committee and files released by the DOJ—thousands of notes, lists, videos and investigation records—have once again raised the question of why so many prominent scholars were involved with Epstein.

The financier widely courted punditspoliticians and billionaires, as the DOJ files confirm with photographs of everyone from Mick Jagger to Bill Clinton to Donald Trump appearing with him. (None are charged with wrongdoing in connection to the photographs.) A piano virtuosomysteriously wealthy and famously ingratiating, Epstein courted scientists for years, leading to investigations at the Massachusetts Institute of Technology and Harvard, the results of which were made public in 2020. Last year’s e-mail releases revealed that astronomer Lawrence Krauss and linguist Noam Chomsky both associated with him long after his crimes became public knowledge. Last November Harvard launched a new investigation to look at connections between Epstein and economist Lawrence Summers, former president of the university.

Patronage

Money is one easy answer for why scientists were interested in Epstein. “Scientists need patronage; they need support,” says Bruce Lewenstein, a science communications expert at Cornell University. Wealthy patrons have funded scientists for centuries; they have paid for telescopes to investigate the atmospheres of alien worldsbrain mapping institutesmalaria prevention experiments, and much else. “That’s not good or bad; that’s what it is. And that has been true for 400 years,” Lewenstein says. Unlike many donors, Epstein usually wasn’t asking for his name on a building, and he donated money to everything from dance troupes to the Council on Foreign Relations, according to a 2019 Miami Herald report.

Curated by Our Editors

Before his 2008 conviction for soliciting minors for prostitution, Epstein donated more than $9 million to Harvard, including a $6.5-million gift to Harvard’s Program for Evolutionary Dynamics (PED), led by mathematician Martin Nowak. (Epstein continued to visit that program after his conviction—he did so more than 40 times in 2018 alone—and kept an office there.) He was also a Visiting Fellow at the university in the 2005–2006 academic year, after making a $200,000 gift to its psychology department. Following his conviction, donors he introduced to Harvard scientists gave $9.5 million to the school.

Then there were Epstein’s donations to M.I.T.: he donated $525,000 to the MIT Media Lab and $225,000 to mechanical engineering professor Seth Lloyd. Both gifts came after his 2008 conviction and were handled outside normal channels, according to a university report. Epstein claimed to also have arranged another $7 million in donations from billionaires Bill Gates and Leon Black to the school (Gates denied this, and the university report says there’s no evidence of an effort to “launder” Epstein’s money in the donations).

“The only generalization is that scientists, like the universities they work for, together with artists and others in nonprofit ventures that depend on philanthropy, routinely cozy up to wealthy people willing to slosh money around,” Pinker says. “Very few of these donors are heinous psychopaths, and he exploited their gullibility.”

According to Pinker, his pre-TED Talk flight with Epstein came at the behest of his literary agent, John Brockman, whose Edge Foundation also threw salons for Epstein that BuzzFeed News described as an “exclusive intellectual boys club.” (Brockman and his organization did not respond to a request for comment, and no reports of wrongdoing attended the events.) Epstein funded that foundation, which threw parties for billionaires and made contacts with people such as Pinker for him. Those contacts paid off: despite his dislike for Epstein, Pinker unwittingly contributed to the financier’s legal defense. Pinker wrote a 2007 opinion on the semantics of the wording of a prostitution law as a favor for Harvard professor Alan Dershowitz, who was Epstein’s lawyer and had once taught a course with Pinker. Pinker has said he didn’t know the opinion was for Epstein’s defense.

“I was doing a professional courtesy to a colleague—it’s routine,” Pinker says. “If I knew at the time what we know now, I would not have agreed.”

A man standing in front of a chalkboard that is covered in equations.
Epstein in a Harvard classroom in September 2004.Rick Friedman/Alamy

Celebrity

So, legal opinions aside, what did Epstein want from science? The simplest explanation is that Epstein collected prominent people. His financial networking relied on creating an aura of wealth and influence to entice investors. He was a “people collector” who traded information and favors, said Barry Levine, one of his biographers, in a 2025 BBC report. Scientists might have just been one of many influential groups he cultivated at a time that was “a cultural high-water mark for scientists as celebrities,” says Declan Fahy, an associate professor of science communication at Dublin City University in Ireland and author of The New Celebrity Scientists. Scientists wrote best-selling books, appeared in Vanity Fair and Vogue and gave viral TED Talks that were elevated online. “They moved into the power elite,” Fahy says, and so made sense for Epstein to cultivate.

Sign Up for Our Daily Newsletter

I agree my information will be processed in accordance with the Scientific American and Springer Nature Limited Privacy Policy. We leverage third party services to both verify and deliver email. By providing your email address, you also consent to having the email address shared with third parties for those purposes.Sign Up

According to Ghislaine Maxwell, Epstein’s former girlfriend and majordomo, who was convicted in 2021 of sex trafficking, conspiracy and transportation of a minor for illegal sexual activity, Epstein was particularly fascinated by brain science. In a July 2025 interview Maxwell told the DOJ that connections she had made through her father, Robert Maxwell, founder of scientific publisher Pergamon Press, led to her introducing Epstein to the Santa Fe Institute, a home to many high-profile scientists. (Epstein donated $25,000 to the institute in 2010.) “Epstein would have dinners at the house that I was tasked to organize and the scientists were a very major component of that,” she said, according to the DOJ transcript.

The scientist and writer Evgeny Morozov attributed Epstein’s scientific connections to Brockman—the literary agent who, according to Pinker, talked the psychologist onto Epstein’s plane—in a 2019 article in the New Republic. Himself a former Brockman client, Morozov recounted the agent’s attempts to connect him to Epstein and his “billionaires’ dinners,” whose attendees often were TED Talk speakers—invitations that Morozov declined.

The Edge Foundation was ubiquitous in science writing circles from 1998 to 2018, annually publishing books on scientific topics. It was also connected to the physicist Lawrence Krauss, a former member of Scientific American’s board of advisers, who was removed following sexual misconduct allegations in 2018. Released e-mail records show that Krauss asked Epstein for advice on handling those charges. Krauss has denied the misconduct allegations against him; none of the communications cited allege wrongdoing in connection with Epstein. (In 2014 Epstein was even invited to two Scientific American editorial meetings, which he did not attend.) Public records suggest the Edge Foundation received $638,000 from Epstein from 2001 to 2015, making him its major funder.

Social Prosthetics

One disturbing explanation for Epstein’s support of science comes from his interest in genetic determinism. This idea, which dates to the eugenics era, is still fashionable in some wealthy circles and can be seen in companies now offering designer baby services for embryos of would-be parents. In 2019 the New York Times reported that Epstein had ambitions of founding a “baby ranch” to raise children of women he impregnated (not unlike “secret compound” plans reportedly shared by SpaceX and Tesla chief Elon Musk).

“Given this stance, it is particularly disturbing that he focused his largesse on research on the genetic basis of human behavior,” wrote Naomi Oreskes, a historian of science, in Scientific American in 2020. “Scientists might claim that Epstein’s money in no way caused them to lower their standards, but we have broad evidence that the interests of funders often influence the work done.” (Regarding Epstein, Oreskes now adds, “The continued press attention reminds us that—rightly or wrongly—we are judged by the company we keep, and some money is tainted.”)

Perhaps the only direct evidence of Epstein’s scientific ambitions comes from a proposal he made in 2005 to be a Visiting Fellow at Harvard. “I wish to study the reasons behind group behavior, such as ‘social prosthetic systems,’” he wrote in an application proposing magnetic resonance imaging studies on human volunteers. “That is, other people can act as ‘prosthetics’ insofar as they augment our cognitive abilities and help us to regulate our emotions—and thereby essentially serve as extensions of ourselves,” he added, with a scientific gloss neatly encapsulating his view of humanity’s role in his life. Harvard approved him twice for the fellowship, though a 2020 investigation later noted his utter lack of qualifications.

A Rocky Pedestal

One last question is why anyone is surprised that celebrity scientists fell into Epstein’s orbit—as opposed to, say, rock stars or politicians doing so—in a culture driven by the worship of wealth and celebrity.

“A bit of this is [because] we have created an idealized picture of scientists that doesn’t match reality,” Lewenstein says. Scientists themselves like being seen as experts with their status on a pedestal, he adds. “They are very reluctant to acknowledge the social forces that shape their science,” Lewenstein says.

In other words, money talks in science. For decades, pharmaceutical-industry-funded research, for example, has more often reported favorable results in medicine. And money can control what science projects don’t get done; social media companies such as Facebook and X (formerly Twitter) have shut out researchers from examining their data—a vast, barely regulated experiment on billions of people linked to worse mental health in children. At the National Institutes of Health right now, in a very different era for science than one of celebrity, Trump administration political appointees are approving or disapproving allocations of the agency’s $48-billion budget for investigations judged as worthy by actual scientists, overturning the post–World War II standards for funding research.

Most of the scientists supported by Epstein weren’t overtly political and supported a once-uncontroversial view of science as an engine of progress, Fahy says. Things are different now, “where public debate around science in the U.S.—particularly around climate and vaccination—has become sharper, divisive, intensely political,” he adds.

All that leaves Pinker unsure why his four seconds on the plane in 2002 was the only video in the Epstein files to be initially released by the Trump administration. One reason might be to generate news stories such as this one about scientists, he says. “The more that journalists write about other people in photos, the less attention Trump’s entanglement gets,” Pinker says.

Rights & Permissions

Dan Vergano is senior editor, Washington, D.C., at Scientific American. He has previously written for Grid News, BuzzFeed News, National Geographic and USA Today. He ischair of the New Horizons committee for the Council for the Advancement of Science Writing and a journalism award judge for both the American Association for the Advancement of Science and the U.S. National Academies of Sciences, Engineering, and Medicine.

More by Dan Vergano

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can’t-miss newsletters, must-watch videos, challenging games, and the science world’s best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe

Posted in Uncategorized | Tagged , , , , | Leave a comment

Qualified Health and the University of Texas System use Claude to identify patients who need life-saving care

Get started

Get started

Industry:

Healthcare

Company size:

Large

Product:

AI Platform

Location:

North America

4–6 million patients per year

in Texas qualify for evidence-based interventions but never get identified

1 million+ patient population

at The University of Texas Medical Branch now being screened by protocols built on Claude to identify candidates for intervention

Qualified Health is a healthcare-native AI platform that identifies patients who qualify for life-saving treatments and improved evidence-based management but who would otherwise go undetected. The University of Texas System is one of the largest public university systems in the United States, with health institutions serving patients across Texas.

With Claude, Qualified Health and the UT System:

  • Screen a 2 million patient population to identify candidates for life-saving interventions
  • Route eligible patients directly into clinicians’ workflows with supporting documentation
  • Complete chart reviews in minutes that previously required extensive manual abstraction
  • Identify patients who benefit from medication optimization, therapeutic intervention, or further discussion
  • Plan to expand from cardiology to primary care, vascular, GI, rheumatology, and neurology by end of 2026

The problem

In Texas, almost every county experiences some critical physician shortage. Healthcare providers know that catching diseases earlier leads to better outcomes, but the information needed to identify at-risk patients is buried in fragmented clinical data that no human could reasonably review at scale.

“People both want and deserve a level of access to healthcare that our workforce can’t realistically deliver without AI augmentation,” said Dr. Peter McCaffrey, Chief Digital and AI Officer at the University of Texas Medical Branch (UTMB).

Healthcare systems spent years digitizing their records, but digitization didn’t make the data usable. “The problem we face is literally one of search, retrieval, and comprehension,” McCaffrey said. “It’s 90% of what we do. It’s where so much of our workforce gets burned out and it’s where most care gaps accumulate. The size and scope of that data are only growing, the breadth of our responsibility to patients is only growing, but our workforce is not keeping pace.”

Organizations ended up with vast amounts of unstructured clinical notes, imaging reports, and test results scattered across disconnected systems. A patient may receive a new diagnosis of heart failure and may be started on therapy, but those medications and dosages may not align with the latest guidelines. Meanwhile, a Cardiology team–even at the same hospital–may be aware of the latest guidelines, but they would not be aware of whether newly diagnosed patients are receiving guideline-directed care even though doing so improves mortality. In Texas, an estimated 4–6 million patients qualify for evidence-based interventions each year and never get identified—resulting in preventable deaths, avoidable complications, and growing strain on the healthcare system.

Claude powers population-scale patient identification

Qualified Health built an AI platform with Claude Sonnet 4.5 to help health systems identify patients who qualify for proven, evidence-based interventions at population scale. Claude was selected following a structured evaluation of multiple models, based on its performance in accurately extracting clinical information, minimizing hallucinations, and producing outputs that are fully traceable to source data, capabilities required for safe use in clinical settings.

The platform integrates fragmented clinical data, such as notes, laboratory results, imaging, and procedural records, and applies precise, guideline-based clinical criteria to determine patient eligibility across a broad set of cardiology practices. 

Patients who meet those criteria are surfaced directly into clinicians’ existing workflows for review, with supporting documentation generated to trace each finding back to source data. This approach shortens the path from identification to treatment while preserving clinician oversight, enabling health systems to deliver evidence-based care more consistently and at a scale that was previously infeasible.

From reactive care to proactive intervention

Justin Norden, MD, a physician and computer scientist, founded Qualified Health to help health systems deploy AI safely and at scale across clinical and administrative operations, enabling clinicians to find and treat patients who would otherwise fall through the cracks. His previous company focused on algorithm safety and trust in high-risk environments before being acquired for autonomous vehicle applications. That background shaped Qualified Health’s approach: building the infrastructure needed to monitor, validate, and govern AI performance in high-risk healthcare settings.

“If we caught patients earlier and intervened, that would be better for everyone. That’s very well known,” said Norden. “What is not yet well known is that today, we have the potential to do that.”

The partnership with the UT System began when Dr. McCaffrey was expanding his AI leadership role at UTMB. The institution needed a partner who could help them move fast and demonstrate real value, not just run interesting experiments. “We’re not so much interested in, oh, you did something that looks cool on a poster,” Dr. McCaffrey explained. “At this stage, we need true examples where AI is deployed in practice and it brings value to care because that is our mandate.”

For cardiologists at UTMB’s Sealy Heart and Vascular Institute, the workflow is straightforward. They log into Qualified Health’s platform and see a census of patients who have been pre-screened by AI and who have opportunities for more optimized management in areas like heart-failure and valvular disease. The system then brings forward relevant medical and historical context balanced with evidence-based appropriateness criteria to highlight those who might otherwise go unnoticed but who would benefit from improved management. The Claude-powered AI platform surfaces relevant details from each patient’s chart, extracting and synthesizing information that would be impossible to manually compile across a patient population.

“I could spend hours looking through charts and find things to worry about,” Norden said. “But you can’t do that on 10,000 patients.” The system doesn’t replace clinical judgment, he added. It amplifies it, enabling clinicians to apply their expertise at a scope that was previously impossible.

Choosing Claude for clinical accuracy

Qualified Health continuously evaluates multiple large language models through a rigorous internal benchmarking process that combines automated testing with structured review by practicing physicians. Models are assessed on their ability to accurately extract structured clinical information from complex source data, minimize failure modes such as hallucinations, and provide traceable citations back to underlying records.

“Our focus is on precision and reliability,” Norden said. “We need models that can consistently identify the right clinical signals, avoid introducing errors, and make every output fully referenceable to the source data. In our evaluations for this work, Claude demonstrated the strongest performance across those dimensions.”

“Safety is non-negotiable in healthcare,” Norden added. “Anthropic has been a clear leader in building models with strong safety foundations, and that was an important factor in our decision-making.”

The validation process reflects Qualified Health’s roots in algorithmic safety and clinical rigor. Each deployment follows a staged approach that includes retrospective back-testing on historical data, automated evaluations, structured physician review, and controlled rollouts prior to broader use with partners.

“There are no fully automated clinical decisions being made,” Norden emphasized. “Every output is reviewed by clinicians, with direct validation against source data. Human oversight is built into the system by design.”

The outcome

In the first month of deployment, the platform revealed that as many as a third of patients with heart failure have opportunities for improved optimization in guideline directed medical therapy. In the initial wave of review, this translated into dozens of patients with opportunities for evidence-based improvement in medication management which cardiologists could then validate and notify care teams. “This is a great example of AI actively augmenting the clinical workforce”, McCaffrey said. “It’s well known that many patients with heart failure can benefit from improved pharmacologic management but examining this adherence and medication practice across a population just isn’t feasible; we don’t have the clinician bandwidth for that.”

The approach extends beyond cardiology. “We started in cardiology, but this isn’t just a cardiology tool,” McCaffrey noted. “It’s the same problem everywhere—there’s a patient in GI with early cirrhosis, there’s someone in vascular with an aneurysm that’s never been flagged. The information is there. We just haven’t had a scalable way to surface it. The need isn’t for AI to make medical decisions; instead, the need is to bring buried issues to the foreground so that clinicians can make medical decisions.”

Cardiology was a deliberate starting point as a specialty with well-established diagnostic criteria, clear clinical guidelines, and availability of proven interventions with life-saving potential.

Building on UTMB’s success, the initiative is now expanding system-wide. By the end of 2026, new deployments will help health systems across Texas identify patients eligible for evidence-based treatments in primary care, vascular, gastrointestinal, rheumatology, and neurology specialties. Dr. McCaffrey chairs AI work across all UT System health institutions, and the system views itself as responsible for all Texans across its exceptional geographic, medical, and socioeconomic diversity.

Dr. McCaffrey added: “Being able to scale that intelligence, that clinical reasoning, to everyone, everywhere is a really inherent social good.” 

‍Worth accessing:

Qualified Healthhttps://www.qualifiedhealthai.com

Advancing Claude in healthcare and the life sciences

Transform healthcare from insight to action

Read more

Read more

Claude for Healthcare

Claude helps healthcare organizations move faster without sacrificing accuracy, safety, or compliance. Less administrative work, more time with the people you serve.

Read more

Read more

“Safety is non-negotiable in healthcare. Anthropic has been a clear leader in building models with strong safety foundations.”

Justin Norden, MD

Co-Founder, Qualified Health

Posted in Uncategorized | Tagged , , , , | Leave a comment

Hassan Sajwani: “This is an engineer from Elon Musk’s xAI …

Posted in Uncategorized | Leave a comment

The Economist: Who had the most contact with Jeffrey Epstein in the final decade of his life?

Posted in Uncategorized | Leave a comment

In 2012, Jeffrey Epstein spent more than $200,000 to get his last lover, Karina Shuliak, into Columbia University’s dental school.

Chay Bowes

@BowesChay

In 2012, Jeffrey Epstein spent more than $200,000 to get his last lover, Karina Shuliak, into Columbia University’s dental school. She initially failed the selection process, but Epstein told the university he would donate between $5 million and $10 million, the dean of the dental school received $100,000 for his research project, and another $50,000 went into the faculty’s “budget” As a result, Shuliak was able to transfer from a Belarusian university despite violating deadlines, and an individual study program was prepared for her. The key link in this “arrangement” was Epstein’s personal dentist, Thomas Mangani. After the scandal, Mangani left the Columbia University admissions committee, and Professor Letty Moss-Salanté was stripped of her administrative duties. Former dean Ira Lamster, who left the university in 2017, said he knew about Epstein’s crimes but believed he had “paid back society for his sins”.

Posted in Uncategorized | Leave a comment

OCCRP: Much of the frenzied Jeffrey Epstein commentary over the past two weeks has focused on individual examples of moral depravity.But there’s a wider, more systemic story here.

February 13, 2026

Greetings from Amsterdam,

Much of the frenzied Jeffrey Epstein commentary over the past two weeks has focused on individual examples of moral depravity. But there’s a wider, more systemic story here. As Seva Gunitsky, a political scientist at the University of Toronto, has argued, the documents “suggest a reframing of Epstein’s case from one man’s crimes to transnational geopolitics.”Viewed through this lens, Epstein’s incredible collection of powerful and influential contacts, from tech billionaires to FSB officers, perfectly exemplifies a new transnational elite — one that has “built fortunes by moving money across jurisdictions, leveraging kompromat, and treating governments as service providers instead of sovereigns.”Epstein’s role shows how this class of operators has been enabled by willing Western partners. Our recent reporting offers three snapshots of how that works.


Start with Senegal: the documents trace a years-long relationship between Epstein and Karim Wade, son of former President Abdoulaye Wade and once one of the country’s most powerful ministers. After Wade’s corruption conviction, his team sought help lobbying in Washington — and turned to Epstein for guidance.Then Venezuela: emails show Epstein buying bonds tied to PDVSA, the state oil company, on the advice of Francisco D’Agostino — a Chávez-era insider now wanted by Venezuelan authorities on money-laundering and criminal-association charges.

Epstein’s social capital also paid dividends back in New York. Emails indicate he worked to secure employment at the International Peace Institute — a respected policy institution tied to the United Nations — for a Russian romantic partner. He may even have subsidized her pay. The commonality in these vignettes is not sex, and it’s not even ideology. It’s the indispensable role of powerful intermediaries who can turn money into legitimacy, access, and impunity — not to mention a powerful reminder of how much of this brokerage usually happens in the dark.The analysis above is a free preview of our upcoming OCCRP PRO membership, a new offering tailored to professionals who rely on our investigations for work in finance, law, compliance, risk management, policy, and related fields. Interested to learn more? Let us know and tell us what you need! Your feedback will directly shape the services we build.OCCRP Exclusive
Posted in Uncategorized | Tagged , , , , | Leave a comment

CNN: Epstein paid for novel genetic testing in apparent effort to explore extending life, new emails show

Epstein paid for novel genetic testing in apparent effort to explore extending life, new emails show

By

Sarah Owermohle

Updated Feb 6, 2026

Late financier and convicted sex offender Jeffrey Epstein is seen in this image from the U.S. Justice Department’s file of Epstein, released by the House Oversight Committee Democrats Washington, D.C., on December 18, 2025.

Late financier and convicted sex offender Jeffrey Epstein is seen in this image from the U.S. Justice Department’s file of Epstein, released by the House Oversight Committee Democrats Washington, D.C., on December 18, 2025. House Oversight Committee Democrats/Reuters

Convicted sex offender Jeffrey Epstein paid for genetic testing in an apparent bid to harness his own genetic material for regenerative medicine – which is aimed at repairing the body by developing new tissues and organs as the old ones wear out – according to newly released emails in the Epstein files.

Several years after Epstein was convicted of soliciting prostitution, including of a minor, in 2008, he paid for novel tests from a doctor at one of America’s preeminent hospitals and explored creating stem cells central to immunity and healing.

The researcher, Joseph Thakuria, was at the time a senior doctor at Massachusetts General Hospital (MGH) in Boston and affiliated with a large-scale genomic studies project at Harvard Medical School.

In a statement to CNN, Thakuria said Epstein was also enrolled in the Harvard Personal Genome Project, a massive public global database of genetic information from volunteers for scientists and researchers to learn more about traits and genes.

Thakuria has not been publicly linked to Epstein before and is not accused of any wrongdoing.

A Harvard representative said MGH is an affiliate of Harvard, but Thakuria was not directly employed by Harvard or the Wyss Institute, which oversees the Personal Genome Project. MGH has no record of approving Thakuria for studies described in the Epstein emails.

Thakuria left the hospital in 2022, an MGH spokesperson said.

Among the documents in the Epstein files released by the Justice Department is a proposal that Thakuria sent Epstein in February 2014, appealing to him to fund a private project that would sequence his patients’ genomes to learn about genetic drivers for their diseases. In the proposal, he also raises options for genetic investigations specifically for Epstein.

A few months later, in June, Thakuria sent Epstein an extensive invoice for a range of projects that included an initial $2,000 investment for sequencing part of Epstein’s genome. The invoice included an estimated cost for “personalized longevity studies” that proposed using gene editing. The invoice indicated that Epstein gave a saliva sample.

The initial investment included $1,000 to sequence a portion of his genome known as the exome, and $1,000 to sequence fibroblasts, which are cells found in connective tissue such as skin and muscles, and that have been used in a relatively new field of research aimed at reversing aging.

Epstein’s staff sent a $2,000 check the same day.

Billionaire Jeffrey Epstein in Cambridge, Massachusetts in 2004.

Billionaire Jeffrey Epstein in Cambridge, Massachusetts in 2004. Rick Friedman/Corbis/Getty Images

“Mr. Epstein was enrolled in the Personal Genome Project, which would study his genetic predisposition to various health conditions. At one point, a $2,000 check was provided to cover DNA sequencing,” Thakuria said in the statement.

“I was a physician-researcher and he [Epstein] was a research subject,” he added. “We also had early discussions about his potentially funding research, but that never materialized.”

“I feel terrible about what his victims went through, and I regret at that time not knowing more about his background and the extent of his crimes,” Thakuria said.

Part of the proposal involved editing Epstein’s stem cells “to introduce mutations in culture believed to increase longevity,” using the then-novel gene editing technology CRISPR, Thakuria wrote.

“I’m only offering this to Jeffrey. Because of all the labor involved, there’s simply not enough bandwidth to offer this to more than a handful of people right now,” he added.

The invoice gave a range of options for future research such as creating new stem cells starting at $10,000, and broader longevity studies that included other patients, and indicated that it could cost “$11,400 for his [Epstein’s] whole genome ($21,000 if he wanted to include both of his parents; not sure if this is even feasible)” to be sequenced.

The full breadth of the projects proposed as described in the invoice would have cost $193,400.

CNN did not find a record of Epstein paying for those services, but emails continued between Thakuria, Epstein and his assistants until at least 2015. In these, Epstein’s assistants sought to follow up on Thakuria’s initial work. At one point, Epstein became annoyed with Thakuria for delays and threatened to report him to his bosses if results did not come quickly.

EFTA00348068-1.jpg

Department of Justice

Epstein died by suicide in 2019 while awaiting trial on federal sex-trafficking charges.

The disgraced financier had long been interested in gene editing. Through his now-defunct foundation, Epstein donated to the World Transhumanist Association, now called Humanity+, as the New York Times first reported in 2019. Humanity+ advocates for “technology and evidence-based science to expand human capabilities” and reverse aging.

Epstein also reportedly had discussions with scientists where he mulled using his own genes to seed a new human race.

The most recently released emails shed new light on Epstein’s relationships with top scientists in the field of genomics research and raise questions about how some may have sought funding from him.

In his statement to CNN, Thakuria said he was introduced to Epstein by George Church, a high-profile Harvard genomics researcher, as a potential research subject for the Personal Genome Project.

Church, who has pioneered gene editing with the then-novel CRISPR technology — used to cut, add and modify specific genetic sequences — has previously been associated with Epstein, who emailed with him frequently and donated funds to his research. Church apologized in 2019 for his continued association with Epstein, calling it “nerd tunnel vision” in an interview with STAT.

Church, who has not been accused of any wrongdoing related to Epstein, did not return a request for comment from CNN. The spokesperson for Harvard referred CNN to Church’s remarks from 2019 in response to questions about him.

Some of what Thakuria described in his invoice was opaque. The largest single item in the invoice was $160,000 for research he called “The Venus Project.”

EFTA02698643-2.jpg

Department of Justice

“Jeffrey and [I] briefly discussed a genomic research studying [sic] I’m dubbing the Venus project (he’ll know what this),” Thakuria wrote in the June 2014 invoice. “I can do this for him but doing this work would be greatly aided by having some good bioinformatic infrastructure.”

“[Epstein] mentioned 200 participants being in this project — I can deliver on this ‘Venus’ research,” he added.

In his statement to CNN, Thakuria said the project was “an idea of Mr. Epstein that was very preliminary and never went anywhere.”

“He was interested in the genetics of facial features. There was no funding, and no research.”

Posted in Uncategorized | Tagged , , , , | Leave a comment

Sky News: Extremists jailed for plotting ‘deadliest’ terror attack on UK Jewish community

Posted in Uncategorized | Leave a comment